HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,968 | +20.4% | 25,658 | +7.0% | 0.02% | +25.0% |
| Q2 2023 | $2,466 | -10.2% | 23,972 | -4.7% | 0.02% | -13.0% |
| Q1 2023 | $2,745 | -2.6% | 25,151 | +1.6% | 0.02% | -8.0% |
| Q4 2022 | $2,817 | -99.8% | 24,750 | -0.2% | 0.02% | +66.7% |
| Q3 2022 | $1,534,000 | -27.2% | 24,793 | -6.2% | 0.02% | -25.0% |
| Q2 2022 | $2,107,000 | -9.4% | 26,419 | +19.6% | 0.02% | +11.1% |
| Q1 2022 | $2,325,000 | -51.3% | 22,095 | -50.1% | 0.02% | 0.0% |
| Q4 2021 | $4,772,000 | +62.6% | 44,284 | +65.3% | 0.02% | -28.0% |
| Q3 2021 | $2,935,000 | +8.5% | 26,798 | -7.3% | 0.02% | +13.6% |
| Q2 2021 | $2,706,000 | -16.3% | 28,898 | -17.8% | 0.02% | -81.8% |
| Q1 2021 | $3,234,000 | +15.4% | 35,142 | -8.3% | 0.12% | +14.2% |
| Q4 2020 | $2,803,000 | -5.8% | 38,325 | +0.0% | 0.11% | -17.8% |
| Q3 2020 | $2,977,000 | +44.9% | 38,321 | +3.6% | 0.13% | +35.8% |
| Q2 2020 | $2,055,000 | +68.6% | 36,974 | -10.2% | 0.10% | +216.7% |
| Q1 2020 | $1,219,000 | -19.5% | 41,163 | -1.6% | 0.03% | +7.1% |
| Q4 2019 | $1,515,000 | +47.7% | 41,844 | +11.1% | 0.03% | +27.3% |
| Q3 2019 | $1,026,000 | +14.5% | 37,676 | +1.2% | 0.02% | +4.8% |
| Q2 2019 | $896,000 | – | 37,247 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |